SCHEMBL669933

SCHEMBL669933

O=c1cc[nH]c2ncc(F)cc12

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AXL P30530 2/20 0.42
PRKCI P41743 2/20 0.42
ADORA2A P29274 1/20 0.42
ADORA1 P30542 1/20 0.42
MKNK1 Q9BUB5 1/20 0.41
MKNK2 Q9HBH9 1/20 0.41
TRPA1 O75762 1/20 0.40
CCR8 P51685 1/20 0.39
KMT2A Q03164 1/20 0.38
NUDT1 P36639 1/20 0.38
MAPK1 P28482 1/20 0.38
PARP1 P09874 1/20 0.38
CSNK1D P48730 1/20 0.37
MAPK14 Q16539 1/20 0.37
ALDH1A1 P00352 1/20 0.37
JAK2 O60674 1/20 0.37
JAK1 P23458 1/20 0.37
JAK3 P52333 1/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10131568 0.79 AURKA (0.47) AXLPRKCIADORA2AADORA1MKNK2
SCHEMBL14697441 0.74 CCR8 (0.52) AXLPRKCIADORA2AADORA1CCR8
SCHEMBL297772 0.73 CDK8 (0.55) AXLMKNK2NUDT1MAPK1CSNK1D
SCHEMBL2700901 0.71 AHR (0.40) CCR8PARP1ALDH1A1HSD17B10
SCHEMBL17844971 0.71 PARP1 (0.57) PARP1JAK2JAK3
SCHEMBL2226029 0.70 ADORA2A (0.44) AXLPRKCIADORA2AADORA1MKNK1
SCHEMBL29381263 0.70 ADORA2A (0.44) AXLPRKCIADORA2AADORA1MKNK1
SCHEMBL25237471 0.70 ADORA2A (0.49) ADORA2AADORA1CCR8KMT2AALDH1A1
SCHEMBL30826139 0.68 DAO (0.41) PARP1ALDH1A1
SCHEMBL29219201 0.68 DAO (0.41) PARP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0153163-B1 7-SUBSTITUTED-1-CYCLOPROPYL-6,8-DIFLUORO-1,4-DIHYDRO-4-OXO-3-QUINOLINECARBOXYLIC ACIDS; 7-SUBSTITUTED-1-CYCLOPROPYL-1,4-DIHYDRO-6-FLUORO-4-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACIDS; THEIR DERIVATIVES; AND A PROCESS FOR PREPARING THE COMPOUNDS WARNER-LAMBERT COMPANY (US) 1989-12-27 EP claimed
EP-2293778-B1 COMPOSITION COMPRISING AN ANTIBIOTIC AND MOMETASONE INTERVET INT BV (NL) 2013-09-18 EP disclosed
US-20120046259-A1 COMPOSITION COMPRISING AN ANTIBIOTIC AND A CORTICOSTEROID INTERVET INC. 2012-02-23 US disclosed
EP-2293778-A2 COMPOSITION COMPRISING AN ANTIBIOTIC AND A CORTICOSTEROID Intervet International B.V. (NL) 2011-03-16 EP disclosed
US-20100087409-A1 COMPOSITION COMPRISING AN ANTIBIOTIC AND A CORTICOSTEROID INTERVET INTERNATIONAL BV 2010-04-08 US disclosed
WO-2009147144-A2 COMPOSITION COMPRISING AN ANTIBIOTIC AND A CORTICOSTEROID INTERVET INTERNATIONAL B.V. (NL) 2009-12-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087409-A1 COMPOSITION COMPRISING AN ANTIBIOTIC AND A CORTICOSTEROID CYP21A2, CYP27A1, NR3C2 AXL 4739/4885PRKCI 3247/4885ADORA2A 1517/4885
US-20120046259-A1 COMPOSITION COMPRISING AN ANTIBIOTIC AND A CORTICOSTEROID CYP21A2, CYP27A1, NR3C2 AXL 4739/4885PRKCI 3247/4885ADORA2A 1517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.